Lisa serves as Vice President of Regulatory Affairs covering both Ergomed CRO and PrimeVigilance. She is also heading our PV Network and RA Intelligence & Analytics division, to ensure streamlining of QPPV and LCPPV operations.
Lisa brings 20 years of multidisciplinary experience within the pharmaceutical industry in regulatory affairs, PV, quality assurance and auditing. Her regulatory expertise encompasses CTA, MAA and post-marketing activities and spans across a wide range of therapeutic indications.
Lisa has an impressive track record of project oversight, supporting regulatory strategies and driving operational execution as well as line management and team leadership. She is a CMC expert with an in-depth knowledge of global regulations and experience in negotiating with regulatory agencies and has led national and CHMP Scientific Advice meetings.
Prior to joining Ergomed, Lisa held leadership positions at WCT and PPD where she provided insightful regulatory consulting, skilfully managed international teams of experts and expanded service capabilities in the realm of regulatory affairs and study start-up delivery.
Lisa earned her Master’s degree in Pharmaceutical Chemistry from the University “La Sapienza” of Rome, Italy.
